ACM
AVNS

Armbruster Capital Management’s Avanos Medical AVNS Stock Holding History

Armbruster Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-37
Closed -$2K – 79
2018
Q1 		$2K Hold
37
– – ﹤0.01% 211
2017
Q4 		$2K Sell
37
-31
-46% -$1.43K ﹤0.01% 251
2017
Q3 		$3K Hold
68
– – ﹤0.01% 233
2017
Q2 		$3K Hold
68
– – ﹤0.01% 251
2017
Q1 		$3K Buy
68
+31
+84% +$1.21K ﹤0.01% 249
2016
Q4 		$1K Hold
37
– – ﹤0.01% 293
2016
Q3 		$1K Hold
37
– – ﹤0.01% 272
2016
Q2 		$1K Buy
+37
New +$1.13K ﹤0.01% 280

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Armbruster Capital Management's AVNS Position: Q2 2018 in Review

Armbruster Capital Management sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 37 shares — an estimated $2K sold.

Armbruster Capital Management first reported a position in AVNS in Q2 2016 and held it in 8 quarters. The position peaked at $3K in Q3 2017. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

  • Armbruster Capital Management reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
  • Armbruster Capital Management sold 37 Avanos Medical shares in Q2 2018, an estimated $2K.
  • Armbruster Capital Management first reported a position in Avanos Medical in Q2 2016 and held it in 8 quarters.
  • Armbruster Capital Management's Avanos Medical position peaked at $3K in Q3 2017.
  • 321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Armbruster Capital Management's 13F filing for Q2 2018, filed 30 Jul 2018.